Please activate JavaScript!
Please install Adobe Flash Player, click here for download

implants international magazine of oral implantology

implants4_2014 AsNewYorkDailyNewsreported,theUSactorCharlie Sheen,bestknownforhisroleasCharlieHarperinthe sitcom“Two and a Half Men”is being sued for sexual assault by a dental technician. The woman claims Sheen, under the influence of drugs, grabbed her breast and tried to tear off her bra at a dental office in LosAngeles.Theactorattackedherduringadentalap- pointment:Thewomanwastryingtoputonamaskfor nitrous oxide on Sheen’s face when he grabbed her breastandpulledatherscrubsandbrastrap.Theden- tal technician also claims that Sheen was high on a combination of crack cocaine, Theradol and alcohol. A representative of the actor,however,denied the ac- cusations and said that Sheen had taken some pain medication prior to the appointment because he had suffered a shoulder injury, and suggested that this medicationhadapparentlynotmixedwellwiththeni- trousoxide. Sheen’slawyer,MartySinger,toldthenewspaperthat the story was entirely unreal and that the lawsuit was only filed for opportunistic reasons. Sheen has been hospitalisedseveraltimesforsubstanceabuse.Hehas facedanumberofchargesforassault,felonyandcrim- inalmischiefinthepast. Dental technician sues actor Charlie Sheen 48 I NEWS In the past,bisphenolA (BPA),a endocrine-disrupting chemical that can also be found in dental composites and sealants, has been linked to a number of health conditions, including obesity, allergies and cancer. Now, researchers have found evidence that prenatal exposure to BPA is associated with diminished lung functionandthedevelopmentofpersistentwheezein children, which are indicators for asthma, one of the mostcommonchronicchildhooddisorders. In order to examine the effect of BPA on lung function and wheeze in children,researchers at the University of Maryland School of Medicine followed women throughpregnancyandtheirchildrenthroughage5.In total, the study included 398 mother–infant dyads. They collected maternal urine samples at 16 and 26 weeks of pregnancy and maternal urine samples an- nuallytoassessBPAexposure. According to the study,prenatal BPA exposure during earlypregnancywasassociatedwithdiminishedlung function, increased likelihood of wheeze, and a per- sistentwheezephenotypeinyoungchildren. AccordingtoestimatesbytheCentresforDiseaseCon- trolandPrevention,about7millionchildrenunderthe age of 18 are affected.Although secondhand smoke andairpollutionhavebeenidentifiedasfactorsforthe developmentofasthmainchildren,thereasonsforin- creasing rates of the disease in the past decades are stillpoorlyunderstoodbyscientists.Thepresentstudy thus provides new evidence that BPA may contribute tothisdevelopment. BPA exposure may contribute to Asthma development in children On October 1, 2014, Danaher Corporation published the public tender offer for all publicly held registered shares of Nobel Biocare Holding AG with a par value of CHF0.40each,asannouncedonSeptember15,2014.TheofferpriceisCHF17.10 incashperregisteredshare. On September 14,2014,Nobel Biocare’s Board of Directors unanimously decided (withonemembernotparticipating)torecommendthatNobelBiocare’ssharehold- ersaccepttheofferofDanaher.TheBoardofDirectorsofNobelBiocarereviewedthe offerindetailanddeterminedthattheall-cashofferisinthebestinterestsofNobel Biocare, its shareholders, employees, customers and suppliers.The report of the BoardofDirectorsregardingtheofferhasbeenpublishedintheofferprospectusof Danahertoday.N+1SwissCapitalAGprovidedafairnessopinionforNobelBiocare’s BoardofDirectorsinwhichitconfirmedthattheofferpriceofCHF17.10incashper registeredshareisfairandappropriatefromafinancialpointofview. On September 29,2014,the SwissTakeover Board decided that the offer of Dana- heriscompliantwiththestatutoryprovisionsrelatingtopublictenderoffers.Dana- herCorporation(NYSE:DHR)isaglobalscienceandtechnologyinnovatorcommit- tedtohelpingitscustomerssolvecomplexchallengesandimprovingqualityoflife aroundtheworld.Itsfamilyofworldclassbrandshaveunparalleledleadershippo- sitions in some of the most demanding and attractive industries, including health care,environmentalandcommunications.Thecompany’sgloballydiverseteamof 66,000associatesisunitedbyacommoncultureandoperatingsystem,theDana- her Business System.In 2013,Danaher generated $19.1 billion in revenue and its marketcapitalizationexceeded$50billion. Danaher Corporation publishes Public tender offer for publicly held shares of Nobel Biocare [PICTURE: ©KENISHIROTIE] [PICTURE: ©IMAGE POINT FR]

Pages Overview